Incorporating Bevacizumab and Erlotinib in the Combined-Modality Treatment of Stage III Non-Small-Cell Lung Cancer: Results of a Phase I/II Trial Article

cited authors

  • Socinski, Mark A.; Stinchcombe, Thomas E.; Moore, Dominic T.; Gettinger, Scott N.; Decker, Roy H.; Petty, W. Jeffrey; Blackstock, A. William; Schwartz, Garry; Lankford, Scott; Khandani, Amir; Morris, David E.

Publication Date

  • November 10, 2012

webpage

published in

category

start page

  • 3953

end page

  • 3959

volume

  • 30

issue

  • 32